|
|
|
|
|
|
BioEnterprise Team
|
|
|
Management | Associates | Board | Partners
 |
Aram Nerpouni,
President & CEO
Aram Nerpouni serves as the President and CEO of BioEnterprise. In this position, he focuses on strategic initiatives as well as counseling clients on business and financial matters. Nerpouni rejoined BioEnterprise in 2011 as Vice President of Strategic Initiatives after serving as the Chief Administrative Officer and a Founder of the Austen BioInnovation Institute in Akron. He was previously a Vice President of Business Development at BioEnterprise and has also worked as Director of International Markets and Director of Marketing at The Bonne Bell Company. Nerpouni serves on the Board of Child Guidance and Family Solutions in Akron and the Knight Foundation Community Advisory Committee. He received an M.B.A. from Case Western Reserve University and a B.S. in Biology from Stanford University.
Click to download photo
|
 |
Annette Ballou,
Vice President, Strategic Marketing & Communications
Annette Ballou leads strategic marketing for BioEnterprise, helping the initiative and its companies in market positioning, message definition, and communication strategy. Ballou has over 20 years of experience in health care marketing and business development in a range of private companies. She has expertise in strategic planning and implementation, business development, marketing, communications and operations. Ballou received her J.D. from Southern Methodist University as well as a B.A. in English and a B.S. in Psychology.
Click to download photo
|
 |
Jen Boland,
CEO-in-Residence
Jen Boland focuses on the development of new biomedical ventures. She has extensive experience in launching and funding high growth ventures. At Cleveland Clinic, Boland assisted spinoff companies by advising companies on raising financing, negotiating licensing agreements, and managing first generation products through design freeze and regulatory submission. Prior to joining Cleveland Clinic, she was responsible for the financial planning and analysis of several business operations within LeapFrog, a venture-backed technology company located in the Bay Area. Her experience also includes roles with a start-up venture within Hewlett-Packard and with an All-American ranked equity research team at Deutsche Banc Alex. Brown. Boland received her MBA from the UC Berkeley Haas School of Business and her BA in Economics from the University of Vermont.
Click to download photo
|
 |
Carol Clark,
Vice President
Carol Clark leads the company’s effort for advising growth stage healthcare opportunities including acquisition-based strategies and is also Managing Director of the Medical Growth Fund. Ms. Clark brings 20 years of experience in structuring and syndicating leveraged buyouts, acquisition financings and business expansion facilities at the Bank of Boston and Aetna Life & Casualty. Recently she was a founding officer and Board member of NineSigma, a Cleveland-based technology start-up. She served as the company's CFO and was a key member of the private equity fundraising team. Currently she serves on the Industry Advisory Board for the Cornell Center for Technology Enterprise and Commercialization. Ms. Clark, a CFA, received an M.B.A. from Cornell University and a B.A. from Wesleyan University.
Click to download photo
|
 |
Russ Donda,
Entrepreneur in Residence, Biosensors
Russ Donda is currently serving as the Entrepreneur in Residence for biosensor technologies at BioEnterprise and the Great Lakes Innovation & Development Enterprise. He has over 25 years of management experience at both executive and entrepreneurial levels, with a background in very early stage companies. Russ is familiar with start-up operations, strategic planning, development related issues, marketing, patent law, intellectual property management, and strategic alliance structuring. He was the founding CEO of ViewRay Incorporated, a founding manager at Regeneration Technologies, and a founding member and co-chair of investment review for the angel group, The Emergent Growth Fund.
Click to download photo
|
 |
Brian Duncan, M.D., M.B.A.,
Vice President
Brian Duncan, M.D., is a Vice President on the medical devices team at BioEnterprise. Duncan is a cardiac surgeon who has more than 20 years of clinical experience. After completing training at Massachusetts General Hospital, he was a staff surgeon at Children’s Hospital in Boston, Seattle Children’s Hospital and Cleveland Clinic. Duncan also has experience developing pediatric ventricular assist devices. Most recently, Duncan was the Medical Director for Cleveland Clinic Emerging Businesses Unit. He has authored more than 100 peer-reviewed manuscripts, 25 book chapters, and the definitive textbook on pediatric circulatory support entitled Mechanical Support for Cardiac and Respiratory Failure in Pediatric Patients. He serves on the boards of BioOhio, American Society for Artificial Internal Organs and Accord Biomaterials. Duncan received his B.S. and M.D. degrees from Indiana University and also has an M.B.A. from the University of Michigan.
Click to download photo
|
|
 |
Glen Gaughan, Ph.D.,
CEO-in-Residence
Glen Gaughan focuses on developing and supporting biopharmaceutical companies for BioEnterprise. He works closely with a number of the companies, supporting the development of their business strategies and operating plans. Gaughan has almost 20 years of experience as a drug discovery scientist with Bristol-Myers Squibb. In roles ranging from Principal Investigator to Group Leader, he contributed to programs searching for new medications for pain, obesity, sleep disorders, and depression, and for contrast agents for MRI. Gaughan designed ProHance, an MRI contrast agent marketed by Bracco. Gaughan holds a Ph.D. in Chemistry from the University of Oregon, an MBA from Case Western Reserve, and a B.A. from Dartmouth.
Click to download photo
|
 |
Elizabeth Greco,
Strategic Development Associate
Elizabeth Greco supports strategic initiatives for BioEnterprise. In this capacity, she focuses on industry accelerating initiatives and communications. Greco received a B.A. from Case Western Reserve University.
Click to download photo
|
 |
Margaret E. Groh, Ph.D.,
Director, Business Development
Meg Groh supports strategic initiatives for BioEnterprise and also oversees the organization's graduate and undergraduate internship programs. She has extensive research experience at the Jefferson Institute of Molecular Medicine, Howard Hughes Medical Institute, the University of Chicago and Case Western Reserve University. Her work covered several areas of molecular medicine including lipid metabolism, molecular cardiology, and stem cell biology. Groh received a Ph.D. from the University of Chicago, a B.S. from Tulane University and an M.B.A. from Case Weatherhead School of Management.
Click to download photo
|
 |
Tatyana Hower,
Director, Business Development
Tatyana Hower focuses on supporting the expansion and attraction of biomedical companies to the Cleveland region. Through her role, she helps connect companies to regional resources and partners, and also to incentives that support their growth. Hower brings ten years of financial industry experience which included the creation of an emerging technology division for a regional bank and unique financing products for life science companies. She is an active member of National Association of Seed and Venture Funds and Ohio Venture Association. Hower holds a Bachelor's Degree from Baldwin-Wallace College.
Click to download photo
|
 |
Bob Johnson,
Vice President
Bob Johnson is a leader of the medical devices team at BioEnterprise. He has an extensive background in the medical device industry across many functions including new ventures, marketing and business development. Johnson has commercialized devices, instrumentation, and diagnostic technologies for cardiology, radiology, obstetrics/gynecology, pulmonology and urology applications. In addition, he has completed numerous transactions including financings, acquisitions, licenses and strategic alliances in his work. Throughout his career, Mr. Johnson has worked in executive capacities for medical device companies including C.R. Bard, Respironics, and Mallinckrodt. Johnson has a B.S. in Business Administration from Loyola University in Baltimore, Maryland.
Click to download photo
|
Photo
Coming
Soon |
R.K. Khosla,
CEO-in-Residence
R.K. Khosla is a serial technology entrepreneuer. In his role, Khosla has successfully launched ChanRx and is engaged in the
development of two other healthcare startups. Prior to BioEnterprise, Khosla was CEO of Peritec Biosciences, a Cleveland Clinic medical device spinout. Khosla has a wide background in finance, entrepreneurship and venture capital. Highlights include two years as a Principal concentrating on wireless technologies at Crystal Ventures, a tech venture fund with $240 million under management with offices in Cleveland, Palo Alto, Singapore & Taipei. He was also CFO and Director of Back Office Operations for All Wound Up which was sold to Borders Group. Khosla started his career at National City in Corporate Banking with the majority of his time being spent in Merchant Banking and Mergers & Acquisitions. Khosla received a BS in Electrical Engineering and Applied Physics with an Economics Minor from Case Western Reserve University and his MBA from Yale.
|
 |
Bill Poore,
Vice President
Bill Poore manages finance and administration functions for both BioEnterprise and BioOhio. The functions include financial projections and statements, grants managements, accounting, personnel administration, and general operations. He brings over 30 years of experience in these areas to BioEnterprise. Poore holds both an MBA in Finance and a BBA in Accounting from Cleveland State University.
Click to download photo
|
 |
David Ricco,
Director, Business Development
David Ricco focuses on the development of the Cleveland Health-Tech Corridor, recruiting innovative and growing healthcare and technology companies to the geography. Prior to joining BioEnterprise, Ricco was employed by both University Hospitals and Cleveland Clinic facilitating new real estate development and expansion initiatives. He was involved in all aspects of real estate development from due diligence and negotiations to regulatory, environmental, and zoning matters to long-term planning. Ricco received a B.S. degree from The University of Akron and a J.D. degree from Case Western Reserve University.
Click to download photo
|
 |
Kaitlin Seibert,
Strategic Development Associate
Kaitlin Seibert focuses on implementing events both at BioEnterprise and through the Northeast Ohio region that benefit entrepreneurs, investors, and small and large companies. Seibert received a B.A. from Case Western Reserve University in Music Performance and Cognitive Science.
Click to download photo
|
|
Photo
Coming
Soon
|
Tom Shaughnessy
Director of Biomedical Manufacturing
Tom Shaughnessy is the Director of Biomedical Manufacturing. In this role he works with manufacturers and the manufacturing supply chain to anticipate and solve problems. Mr. Shaughnessy understands manufacturing requirements, connects medical device companies to appropriate Ohio-based resources, and aligns manufacturers with growing biomedical opportunities. He has extensive experience with manufacturing, having worked with Rockwell, Spine Matrix, Sparton Medical and General Electric. Mr. Shaughnessy received his B.S. in Chemical Engineering from Cleveland State University.
|
 |
Rachel Siegfried,
Strategic Development Analyst
Rachel Siegfried supports BioEnterprise’s strategic initiatives. She has completed community development internships with Summer on the Cuyahoga and the AmeriCorps VISTA program. Siegfried received a B.A. in Anthropology and a M.P.H. in Health Promotion from Case Western Reserve University.
Click to download photo
|
 |
Karen Spilizewski,
Vice President
Karen Spilizewski is a leader of BioEnterprise's medical device team and is also a Vice President with RiverVest Ventures. She brings nearly 20 years of experience in new product development and business development in medical and non-medical technologies. Spilizewski worked as a business development manager at Avery Dennison and in product development roles ranging from research manager to associate. She was responsible for conducting marketing, financial, technical, and competitive analyses of new opportunities for microelectronic, biomedical, optical display, and MEMs applications. In product development roles, she has developed and commercialized products for various medical devices, including wound care, diagnostics, surgical, and electromedical applications. Spilizewski received her MBA, M.S. in Macromolecular Science and a B.S. degree in Biomedical Engineering from Case Western Reserve.
Click to download photo
|
 |
Laurie Toth,
Marketing Manager
Laurie Toth is the marketing manager at BioEnterprise. In this capacity she performs industry market research, produces the quarterly electronic newsletter, facilitates events and conferences and manages the website and IT systems. Ms. Toth received her BA in Business Administration from Baldwin-Wallace College in Berea, Ohio.
Click to download photo
|
 |
Jim Weisman,
Vice President
Jim Weisman leads BioEnterprise’s efforts in serving and developing start-up health care software and service opportunities including the newly formed H.I.T. Accelerator. He brings almost 20 years of experience in general management, having worked in senior management at PepsiCo and Macy’s as well as consulting to major financial institutions while with the First Manhattan Consulting Group. Weisman served on the management team of HealthSync, a start-up company developing marketplaces for defined-contribution based corporate sponsored health insurance. He has worked with Glengary Ventures, a fund focused on technology based companies, and provided consulting and executive management services to early-stage companies in the biotech and satellite communications industries. Weisman received his B.S. in Economics from The Wharton School at the University of Pennsylvania and his Executive MBA from Case Weatherhead School of Management.
Click to download photo
|
|
|
|
|
|